We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Chitosan Offers New Hope for Spinal Injury Victims

By HospiMedica International staff writers
Posted on 26 Apr 2010
A new study has found that chitosan, a common ingredient of crustacean shells, can repair damaged nerve cell membranes in the spinal cord. More...


Researchers at the Purdue School of Veterinary Medicine (West Lafayette, IN, USA) first converted chitin--one of the most common sugars found in crustacean shells--into chitosan. The researchers then isolated a segment of guinea pig spinal cord, compressed a section, applied the modified chitin, and then added a fluorescent dye that could only enter the cells through damaged membranes. If the chitosan repaired the crushed membranes then the spinal cord tissue would be unstained, but if the chitosan had failed, the spinal cord neurons would be flooded with the fluorescent dye. Viewing a section of the spinal cord under the microscope, the researchers were amazed to see that the spinal cord was completely dark; none of the dye had entered the nerve cells. The chitosan had effectively repaired the damaged cell membranes.

Next, the researchers tested whether a dose of chitosan could prevent large molecules from leaking out of damaged spinal cord cells. Testing for the presence of the colossal enzyme lactate dehydrogenase (LDH), the researchers observed that levels of LDH leakage from chitosan treated spinal cord were lower than from undamaged spinal cords. Not only had the sugar repaired membranes at the compression site, it had also done so at other sites, where the cell membranes were broken due to handling. When they further tested for the presence of harmful reactive oxygen species (ROS, released when adenosine triphosphate (ATP) generating mitochondria are damaged) they found that ROS levels also fell after applying chitosan to the damaged tissue, indicating that chitosan probably repairs mitochondrial membranes as well as the nerve cell membranes.

In a further test, the researchers measured the brain's response to nerve signals generated in the hind leg of a guinea pig, and found that the signals were unable to reach the brain through a damaged spinal cord. However, 30 minutes after injecting chitosan into the rodents, the nerve signals returned to the animals' brains. The study was published in the April 16, 2010, issue of the Journal of Experimental Biology.

"This is not like a drug which may work in some species and not in others; this is a mechanical effect,” said lead author professor of developmental anatomy Richard Borgens, Ph.D. "The sugar molecules migrate to the nerve injury target and repair the injured area, not the undamaged area.”

Chitosan is a biocompatible, biodegradable linear polysaccharide composed of randomly distributed β-(1-4)-linked D-glucosamine (deacetylated units) and N-acetyl-D-glucosamine (acetylated units). Chitosan is produced commercially by deacetylation of chitin, which is the structural element in the exoskeleton of crustaceans (crabs, shrimp, etc.) and cell walls of fungi. Chitosan is also a bioadhesive, which readily binds to negatively charged surfaces such as mucosal membranes, and enhances the transport of polar drugs across epithelial surfaces.

Related Links:

Purdue School of Veterinary Medicine




Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammo DR Retrofit Solution
DR Retrofit Mammography
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.